Reply to Lutgring et al
- PMID: 35818862
- DOI: 10.1093/cid/ciac376
Reply to Lutgring et al
Conflict of interest statement
Potential conflicts of interest. C. A. A. reports grants from Merck, Entasis Pharmaceuticals, and MeMed Diagnostics outside of the submitted work. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Comment on
-
Are Vancomycin Non-Susceptible Clostridioides difficile Strains Emerging?Clin Infect Dis. 2022 Oct 29;75(9):1677-1678. doi: 10.1093/cid/ciac375. Clin Infect Dis. 2022. PMID: 35818797 Free PMC article. No abstract available.
Publication types
LinkOut - more resources
Full Text Sources